Damon L. Meyer
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 29
- Radiopharmaceutical Chemistry and Applications 9
-
- Cell Adhesion Molecules Research 7
- Co-authors
- Peter D. SenterCharles G. CervenyJoseph A. FranciscoDana F. ChaceSvetlana O. DoroninaAlan F. WahlBrian E. TokiRoger F. Zabinski
- Journals
- Bioconjugate Chemistry (12 papers)Cancer Research (5 papers)Blood (4 papers)Clinical Cancer Research (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Damon L. Meyer
38 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Radiology, Nuclear Medicine and Imaging 3.0k
- Oncology 2.9k
- Immunology and Allergy 249
- Pathology and Forensic Medicine 597
- Molecular Biology 1.7k
Countries citing papers authored by Damon L. Meyer
This map shows the geographic impact of Damon L. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damon L. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damon L. Meyer more than expected).
Fields of papers citing papers by Damon L. Meyer
This network shows the impact of papers produced by Damon L. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damon L. Meyer. The network helps show where Damon L. Meyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Damon L. Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Decreased Myocilin Expression in Cultured Trabecular Meshwork Cells Induced by a Selective Glucocorticoid Receptor Agonist (SEGRA) Suggests an Improved Ocular Safety Profile Versus Steroids | 2009 | 1 |
| 2 | Trastuzumab-MC-vc-PAB-MMAF: The effects of the Drug:Antibody Ratio (DAR) on efficacy, toxicity and pharmacokinetics. | 2007 | 3 |
| 3 | Humanized anti-CD19 auristatin antibody-drug conjugates display potent antitumor activity in preclinical models of B-cell malignancies | 2007 | 2 |
| 4 | 2007 | 41 | |
| 5 | 2007 | 39 | |
| 6 | 2006 | 222 | |
| 7 | 2005 | 56 | |
| 8 | Immunoconjugates comprised of drugs with impaired cellular permeability: A new approach to targeted therapy | 2004 | 2 |
| 9 | Effect of drug loading on the pharmacology, pharmacokinetics, and toxicity of an anti-CD30 antibody-drug conjugate | 2004 | 0 |
| 10 | 2004 | 84 | |
| 11 | Development of potent monoclonal antibody auristatin conjugates for cancer therapy Hit paper breakdown → | 2003 | 903 |
| 12 | cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity Hit paper breakdown → | 2003 | 668 |
| 13 | 2001 | 121 | |
| 14 | 1995 | 25 | |
| 15 | 1994 | 26 | |
| 16 | 1992 | 34 | |
| 17 | 1990 | 14 | |
| 18 | Preclinical trials with combinations and conjugates of T101 monoclonal antibody and doxorubicin. | 1986 | 52 |
| 19 | 1985 | 32 | |
| 20 | 1983 | 35 |
About Damon L. Meyer
Damon L. Meyer is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Allergy, Oncology, Biotechnology and Cell Biology, having authored 40 papers that have together received 4.9k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (29 papers), HER2/EGFR in Cancer Research (18 papers), Radiopharmaceutical Chemistry and Applications (9 papers), Cell Adhesion Molecules Research (7 papers), Lymphoma Diagnosis and Treatment (5 papers), Click Chemistry and Applications (4 papers), Biotin and Related Studies (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (3.0k citations), Oncology (2.9k citations), Immunology and Allergy (249 citations), Pathology and Forensic Medicine (597 citations) and Molecular Biology (1.7k citations). Damon L. Meyer has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Peter D. Senter, Charles G. Cerveny, Joseph A. Francisco, Dana F. Chace, Svetlana O. Doronina, Alan F. Wahl, Brian E. Toki, Roger F. Zabinski, Clay B. Siegall and Russell J. Sanderson. Their work appears in journals such as Bioconjugate Chemistry, Cancer Research, Blood, Clinical Cancer Research and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.